Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Transplant Technology

Enrichment of cell subpopulations applying automated MACS technique: purity, recovery and applicability for PCR-based chimerism analysis

Abstract

Enrichment of cell subpopulations is a prerequisite for lineage-specific chimerism analysis (LCA), a frequent approach in follow-up after allo-SCT. An efficient enrichment technique is Magnetic Cell Sorting (MACS) using the AutoMACS separator. However, evaluation of purity, recovery and applicability for PCR-based chimerism analysis of MACS-enriched subpopulations from post-transplant peripheral blood, providing reduced cell numbers and/or unbalanced proportions of subpopulations, is currently unavailable. We performed enrichment of CD3-, CD14-, CD15-, CD19- and CD56-positive subpopulations using ‘Whole Blood MicroBeads’ and AutoMACS separator in 137 prospectively collected peripheral blood samples from 15 paediatric patients after allo-CD3-/CD19-depleted SCT. Purity was assessed by immune phenotyping. Recovery and applicability for chimerism analysis was evaluated. Excellent purity >90% was achieved in CD14-, CD15-positive cells in 81%, 95% of the isolates and in 86% of CD3 and CD19 isolates, if ACC was >400 cells per μl. Median purity of CD56-positive isolates was 78.9%. Recovery >90% was between 93 (CD56) and 37% (CD15). Conventional and real-time PCR-based chimerism analysis was feasible in virtually all samples. Isolation of cell subpopulations by automated cell enrichment in post-transplant peripheral blood is feasible and fast providing excellent purity and recovery for routine lineage-specific chimerism analysis.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

References

  1. Bader P, Kreyenberg H, Hoelle W, Dueckers G, Handgretinger R, Lang P et al. Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy? J Clin Oncol. 2004; 22: 1696–1706.

    Article  PubMed  Google Scholar 

  2. Willasch A, Hoelle W, Kreyenberg H, Niethammer D, Handgretinger R, Lang P et al. Outcome of allogeneic stem cell transplantation in children with non-malignant diseases. Haematologica 2006; 91: 788–794.

    PubMed  Google Scholar 

  3. Thiede C, Bornhauser M, Ehninger G . Strategies and clinical implications of chimerism diagnostics after allogeneic hematopoietic stem cell transplantation. Acta Haematol 2004; 112: 16–23.

    Article  PubMed  Google Scholar 

  4. Liesveld JL, Rothberg PG . Mixed chimerism in SCT: conflict or peaceful coexistence? Bone Marrow Transplant 2008; 42: 297–310.

    Article  CAS  PubMed  Google Scholar 

  5. Saito B, Fukuda T, Yokoyama H, Kurosawa S, Takahashi T, Fuji S et al. Impact of T cell chimerism on clinical outcome in 117 patients who underwent allogeneic stem cell transplantation with a busulfan-containing reduced-intensity conditioning regimen. Biol Blood Marrow Transplant 2008; 14: 1148–1155.

    Article  CAS  PubMed  Google Scholar 

  6. Ozyurek E, Cowan MJ, Koerper MA, Baxter-Lowe LA, Dvorak CC, Horn BN . Increasing mixed chimerism and the risk of graft loss in children undergoing allogeneic hematopoietic stem cell transplantation for non-malignant disorders. Bone Marrow Transplant 2008; 42: 83–91.

    Article  CAS  PubMed  Google Scholar 

  7. Lion T, Muller-Berat N . Chimerism testing after allogeneic stem cell transplantation: importance of timing and optimal technique for testing in different clinical-biological situations. Leukemia 2003; 17: 612.

    Article  CAS  PubMed  Google Scholar 

  8. Matthes-Martin S, Lion T, Haas OA, Frommlet F, Daxberger H, Konig M et al. Lineage-specific chimaerism after stem cell transplantation in children following reduced intensity conditioning: potential predictive value of NK cell chimaerism for late graft rejection. Leukemia 2003; 17: 1934–1942.

    Article  CAS  PubMed  Google Scholar 

  9. Lim ZY, Pearce L, Ingram W, Ho AY, Mufti GJ, Pagliuca A . Chimerism does not predict for outcome after alemtuzumab-based conditioning: lineage-specific analysis of chimerism of specific diseases may be more informative. Bone Marrow Transplant 2008; 41: 587–588.

    Article  CAS  PubMed  Google Scholar 

  10. Ringden O . Immunotherapy by allogeneic stem cell transplantation. Adv Cancer Res 2007; 97C: 25–60.

    Article  Google Scholar 

  11. Lion T . Detection of impending graft rejection and relapse by lineage-specific chimerism analysis. Methods Mol Med 2007; 134: 197–216.

    Article  CAS  PubMed  Google Scholar 

  12. Miura Y, Tanaka J, Toubai T, Tsutsumi Y, Kato N, Hirate D et al. Analysis of donor-type chimerism in lineage-specific cell populations after allogeneic myeloablative and non-myeloablative stem cell transplantation. Bone Marrow Transplant. 2006; 37: 837–843.

    Article  CAS  PubMed  Google Scholar 

  13. Zeiser R, Spyridonidis A, Wasch R, Ihorst G, Grullich C, Bertz H et al. Evaluation of immunomodulatory treatment based on conventional and lineage-specific chimerism analysis in patients with myeloid malignancies after myeloablative allogeneic hematopoietic cell transplantation. Leukemia 2005; 19: 814–821.

    Article  CAS  PubMed  Google Scholar 

  14. Bader P, Stoll K, Huber S, Geiselhart A, Handgretinger R, Niemeyer C et al. Characterization of lineage-specific chimaerism in patients with acute leukaemia and myelodysplastic syndrome after allogeneic stem cell transplantation before and after relapse. Br J Haematol 2000; 108: 761–768.

    Article  CAS  PubMed  Google Scholar 

  15. Breuer S, Matthes S, König M, Fritsch G, Pötschger U, Lawitschka A et al. Recipient chimerism in the T-cell lineage is indicative of impending graft rejection in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation. In: 40th Congress of SIOP, abstract book. Wiley-Liss Inc.: Hoboken, NY, USA, 2008, pp 60–61.

    Google Scholar 

  16. Pongers-Willemse MJ, Verhagen OJ, Tibbe GJ, Wijkhuijs AJ, de Haas V, Roovers E et al. Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes. Leukemia 1998; 12: 2006–2014.

    Article  CAS  PubMed  Google Scholar 

  17. Kreyenberg H, Holle W, Mohrle S, Niethammer D, Bader P . Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Tuebingen experience. Leukemia 2003; 17: 237–240.

    Article  CAS  PubMed  Google Scholar 

  18. Watzinger F, Lion T, Steward C . The RSD code: proposal for a nomenclature of allelic configurations in STR-PCR-based chimerism testing after allogeneic stem cell transplantation. Leukemia 2006; 20: 1448–1452.

    Article  CAS  PubMed  Google Scholar 

  19. Scharf SJ, Smith AG, Hansen JA, McFarland C, Erlich HA . Quantitative determination of bone marrow transplant engraftment using fluorescent polymerase chain reaction primers for human identity markers. Blood 1995; 85: 1954–1963.

    CAS  PubMed  Google Scholar 

  20. Willasch A, Schneider G, Reincke BS, Shayegi N, Kreyenberg H, Kuci S et al. Sequence polymorphism systems for quantitative real-time polymerase chain reaction to characterize hematopoietic chimerism-high informativity and sensitivity as well as excellent reproducibility and precision of measurement. Lab Hematol 2007; 13: 73–84.

    Article  CAS  PubMed  Google Scholar 

  21. Steinbach D, Debatin KM . What do we mean by sensitivity when we talk about detecting minimal residual disease? Leukemia 2008; 22: 1638–1639.

    Article  CAS  PubMed  Google Scholar 

  22. The R Foundation for Statistical Computing c/o Institut für Statistik und Wahrscheinlichkeitstheorie der Technischen Universität Wien. R, a language and environment for statistical computing and graphics. University of Vienna, Austria 2003.

  23. Vitale M, Della CM, Carlomagno S, Romagnani C, Thiel A, Moretta L . et al. The small subset of CD56brightCD16- natural killer cells is selectively responsible for both cell proliferation and interferon-gamma production upon interaction with dendritic cells. Eur J Immunol 2004; 34: 1715–1722.

    Article  CAS  PubMed  Google Scholar 

  24. Romagnani C, Juelke K, Falco M, Morandi B, D'Agostino A, Costa R et al. CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation. J Immunol 2007; 178: 4947–4955.

    Article  CAS  PubMed  Google Scholar 

  25. Beck O, Seidl C, Lehrnbecher T, Kreyenberg H, Schwabe D, Klingebiel T et al. Quantification of chimerism within peripheral blood, bone marrow and purified leukocyte subsets: comparison of singleplex and multiplex PCR amplification of short tandem repeat (STR) loci. Eur J Haematol. 2006; 76: 237–244.

    Article  CAS  PubMed  Google Scholar 

  26. Tomblyn M, Lazarus HM . Donor lymphocyte infusions: the long and winding road: how should it be traveled? Bone Marrow Transplant 2008.

  27. Klingebiel T, Bader P . Delayed lymphocyte infusion in children given SCT. Bone Marrow Transplant 2008; 41 (Suppl 2): S23–S26.

    Article  PubMed  Google Scholar 

  28. Formankova R, Sedlacek P, Krskova L, Rihova H, Sramkova L, Star J . Chimerism-directed adoptive immunotherapy in prevention and treatment of post-transplant relapse of leukemia in childhood. Haematologica 2003; 88: 117–118.

    PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by the ‘Adolf Messer Stiftung’, Koenigstein, Germany (PB) and by the ‘Paul und Ursula Klein-Stiftung’, Frankfurt, Germany (AW).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A Willasch.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Willasch, A., Eing, S., Weber, G. et al. Enrichment of cell subpopulations applying automated MACS technique: purity, recovery and applicability for PCR-based chimerism analysis. Bone Marrow Transplant 45, 181–189 (2010). https://doi.org/10.1038/bmt.2009.89

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2009.89

Keywords

This article is cited by

Search

Quick links